Involvement of the Fas System in Hepatitis C Virus Recurrence After Liver Transplantation

作者: Javier Crespo , Monteserrat Rivero , Marta Mayorga , Emilio Fabrega , Fernando Casafont

DOI: 10.1053/JLTS.2000.9742

关键词:

摘要: To date, there have been no reports of the involvement Fas system in recurrent hepatitis C virus (HCV) infection after orthotopic liver transplantation (OLT). In 25 patients who underwent OLT for HCV-related cirrhosis, we evaluated expression antigen (FasAg) on hepatocytes, apoptic and serum levels soluble (sFas). The level HCV viremia genotype were determined by polymerase chain reaction. Serum sFas an enzyme immunoassay procedure. DNA fragmentation was terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate nick end-labeling (TUNEL) technique deparaffinized samples. FasAg immunoperoxidase method. Sixteen had evidence disease. number hepatocytes expressing percentage apoptotic greater among developed than those did not (P < .01 P .0001, respectively). There a correlation between hepatic FasAg, intensity lobular inflammation = .007), TUNEL index .001). with without .04). We conclude that (1) is up-regulated related to grading disease; likewise, hepatitis; (2) demonstration labeling nuclei assay suggest apoptosis mediated may role pathogenesis OLT. (Liver Transpl 2000;6:562-569.)

参考文章(35)
Naoki Hiramatsu, Norio Hayashi, Kazuhiro Katayama, Kiyoshi Mochizuki, Yuko Kawanishi, Akinori Kasahara, Hideyuki Fusamoto, Takenobu Kamada, Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C Hepatology. ,vol. 19, pp. 1354- 1359 ,(1993) , 10.1002/HEP.1840190606
Michael Charlton, Eric Seaberg, Russell Wiesner, James Everhart, Rowen Zetterman, John Lake, Katherine Detre, Jay Hoofnagle, Predictors of patient and graft survival following liver transplantation for hepatitis C Hepatology. ,vol. 28, pp. 823- 830 ,(1998) , 10.1002/HEP.510280333
Muneko Okazaki, Keisuke Hino, Kaori Fujii, Nobuyuki Kobayashi, Kiwamu Okita, Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C. Digestive Diseases and Sciences. ,vol. 41, pp. 2453- 2458 ,(1996) , 10.1007/BF02100142
Marie-Reine Losser, Didier Payen, MECHANISMS OF LIVER DAMAGE Seminars in Liver Disease. ,vol. 16, pp. 357- 367 ,(1996) , 10.1055/S-2007-1007249
William A. Faubion, Gregory J. Gores, Death receptors in liver biology and pathobiology. Hepatology. ,vol. 29, pp. 1- 4 ,(1999) , 10.1002/HEP.510290101
S. Nagata, P. Golstein, The Fas death factor Science. ,vol. 267, pp. 1449- 1456 ,(1995) , 10.1126/SCIENCE.7533326
Jun Ogasawara, Rie Watanabe-Fukunaga, Masashi Adachi, Akio Matsuzawa, Tsutomu Kasugai, Yukihiko Kitamura, Naoto Itoh, Takashi Suda, Shigekazu Nagata, Lethal effect of the anti-Fas antibody in mice Nature. ,vol. 364, pp. 806- 809 ,(1993) , 10.1038/364806A0
Tsunenori Fujita, Satoshi Ishido, Sanshiro Muramatsu, Masae Itoh, Hak Hotta, Suppression of Actinomycin D-Induced Apoptosis by the NS3 Protein of Hepatitis C Virus ☆ Biochemical and Biophysical Research Communications. ,vol. 229, pp. 825- 831 ,(1996) , 10.1006/BBRC.1996.1887
Francesco Negro, Emiliano Giostra, Laura Rubbia-Brandt, Gilles Mentha, Giuseppe Colucci, Philippe Morel, Rafael Quadri, Luc Perrin, Antoine Hadengue, IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation Journal of Medical Virology. ,vol. 56, pp. 224- 229 ,(1998) , 10.1002/(SICI)1096-9071(199811)56:3<224::AID-JMV8>3.0.CO;2-9